Literature DB >> 19339605

JNK-induced MCP-1 production in spinal cord astrocytes contributes to central sensitization and neuropathic pain.

Yong-Jing Gao1, Ling Zhang, Omar Abdel Samad, Marc R Suter, Kawasaki Yasuhiko, Zhen-Zhong Xu, Jong-Yeon Park, Anne-Li Lind, Qiufu Ma, Ru-Rong Ji.   

Abstract

Our previous study showed that activation of c-jun-N-terminal kinase (JNK) in spinal astrocytes plays an important role in neuropathic pain sensitization. We further investigated how JNK regulates neuropathic pain. In cultured astrocytes, tumor necrosis factor alpha (TNF-alpha) transiently activated JNK via TNF receptor-1. Cytokine array indicated that the chemokine CCL2/MCP-1 (monocyte chemoattractant protein-1) was strongly induced by the TNF-alpha/JNK pathway. MCP-1 upregulation by TNF-alpha was dose dependently inhibited by the JNK inhibitors SP600125 (anthra[1,9-cd]pyrazol-6(2H)-one) and D-JNKI-1. Spinal injection of TNF-alpha produced JNK-dependent pain hypersensitivity and MCP-1 upregulation in the spinal cord. Furthermore, spinal nerve ligation (SNL) induced persistent neuropathic pain and MCP-1 upregulation in the spinal cord, and both were suppressed by D-JNKI-1. Remarkably, MCP-1 was primarily induced in spinal cord astrocytes after SNL. Spinal administration of MCP-1 neutralizing antibody attenuated neuropathic pain. Conversely, spinal application of MCP-1 induced heat hyperalgesia and phosphorylation of extracellular signal-regulated kinase in superficial spinal cord dorsal horn neurons, indicative of central sensitization (hyperactivity of dorsal horn neurons). Patch-clamp recordings in lamina II neurons of isolated spinal cord slices showed that MCP-1 not only enhanced spontaneous EPSCs but also potentiated NMDA- and AMPA-induced currents. Finally, the MCP-1 receptor CCR2 was expressed in neurons and some non-neuronal cells in the spinal cord. Together, we have revealed a previously unknown mechanism of MCP-1 induction and action. MCP-1 induction in astrocytes after JNK activation contributes to central sensitization and neuropathic pain facilitation by enhancing excitatory synaptic transmission. Inhibition of the JNK/MCP-1 pathway may provide a new therapy for neuropathic pain management.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19339605      PMCID: PMC2682921          DOI: 10.1523/JNEUROSCI.3623-08.2009

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  77 in total

Review 1.  Chemokines, chemokine receptors and pain.

Authors:  Catherine Abbadie
Journal:  Trends Immunol       Date:  2005-10       Impact factor: 16.687

2.  Runx1 determines nociceptive sensory neuron phenotype and is required for thermal and neuropathic pain.

Authors:  Chih-Li Chen; Daniel C Broom; Yang Liu; Joriene C de Nooij; Zhe Li; Chuan Cen; Omar Abdel Samad; Thomas M Jessell; Clifford J Woolf; Qiufu Ma
Journal:  Neuron       Date:  2006-02-02       Impact factor: 17.173

3.  Intrathecally administered endotoxin or cytokines produce allodynia, hyperalgesia and changes in spinal cord neuronal responses to nociceptive stimuli in the rat.

Authors:  A J Reeve; S Patel; A Fox; K Walker; L Urban
Journal:  Eur J Pain       Date:  2000       Impact factor: 3.931

Review 4.  Neuronal plasticity: increasing the gain in pain.

Authors:  C J Woolf; M W Salter
Journal:  Science       Date:  2000-06-09       Impact factor: 47.728

5.  Mice overexpressing chemokine ligand 2 (CCL2) in astrocytes display enhanced nociceptive responses.

Authors:  J Menetski; S Mistry; M Lu; J S Mudgett; R M Ransohoff; J A Demartino; D E Macintyre; C Abbadie
Journal:  Neuroscience       Date:  2007-08-14       Impact factor: 3.590

6.  Quantitative assessment of tactile allodynia in the rat paw.

Authors:  S R Chaplan; F W Bach; J W Pogrel; J M Chung; T L Yaksh
Journal:  J Neurosci Methods       Date:  1994-07       Impact factor: 2.390

7.  Supraspinal glial-neuronal interactions contribute to descending pain facilitation.

Authors:  Feng Wei; Wei Guo; Shiping Zou; Ke Ren; Ronald Dubner
Journal:  J Neurosci       Date:  2008-10-15       Impact factor: 6.167

8.  Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2.

Authors:  Catherine Abbadie; Jill A Lindia; Anne Marie Cumiskey; Larry B Peterson; John S Mudgett; Ellen K Bayne; Julie A DeMartino; D Euan MacIntyre; Michael J Forrest
Journal:  Proc Natl Acad Sci U S A       Date:  2003-06-13       Impact factor: 11.205

Review 9.  Spinal cord repair strategies: why do they work?

Authors:  Elizabeth J Bradbury; Stephen B McMahon
Journal:  Nat Rev Neurosci       Date:  2006-08       Impact factor: 34.870

10.  Regulation of peripheral inflammation by spinal p38 MAP kinase in rats.

Authors:  David L Boyle; Toni L Jones; Deepa Hammaker; Camille I Svensson; Sanna Rosengren; Salvatore Albani; Linda Sorkin; Gary S Firestein
Journal:  PLoS Med       Date:  2006-09       Impact factor: 11.069

View more
  241 in total

1.  Spinal CCL2 Promotes Central Sensitization, Long-Term Potentiation, and Inflammatory Pain via CCR2: Further Insights into Molecular, Synaptic, and Cellular Mechanisms.

Authors:  Rou-Gang Xie; Yong-Jing Gao; Chul-Kyu Park; Ning Lu; Ceng Luo; Wen-Ting Wang; Sheng-Xi Wu; Ru-Rong Ji
Journal:  Neurosci Bull       Date:  2017-03-06       Impact factor: 5.203

2.  Involvement of calcitonin gene-related peptide and CCL2 production in CD40-mediated behavioral hypersensitivity in a model of neuropathic pain.

Authors:  Jennifer T Malon; Swathi Maddula; Harmony Bell; Ling Cao
Journal:  Neuron Glia Biol       Date:  2012-03-01

3.  The Central Role of Glia in Pathological Pain and the Potential of Targeting the Cannabinoid 2 Receptor for Pain Relief.

Authors:  Jenny L Wilkerson; Erin D Milligan
Journal:  ISRN Anesthesiol       Date:  2011

4.  Characterization of frequency-dependent responses of the vascular system to repetitive vibration.

Authors:  Kristine Krajnak; G Roger Miller; Stacey Waugh; Claud Johnson; Michael L Kashon
Journal:  J Occup Environ Med       Date:  2012-08       Impact factor: 2.162

5.  Spinal injection of TNF-α-activated astrocytes produces persistent pain symptom mechanical allodynia by releasing monocyte chemoattractant protein-1.

Authors:  Yong-Jing Gao; Ling Zhang; Ru-Rong Ji
Journal:  Glia       Date:  2010-11-15       Impact factor: 7.452

Review 6.  Chemokines, neuronal-glial interactions, and central processing of neuropathic pain.

Authors:  Yong-Jing Gao; Ru-Rong Ji
Journal:  Pharmacol Ther       Date:  2010-02-01       Impact factor: 12.310

7.  A p38 mitogen-activated protein kinase-dependent mechanism of disinhibition in spinal synaptic transmission induced by tumor necrosis factor-alpha.

Authors:  Haijun Zhang; Hui Nei; Patrick M Dougherty
Journal:  J Neurosci       Date:  2010-09-22       Impact factor: 6.167

8.  The prostaglandin E2 receptor EP3 controls CC-chemokine ligand 2-mediated neuropathic pain induced by mechanical nerve damage.

Authors:  Elsa-Marie Treutlein; Katharina Kern; Andreas Weigert; Neda Tarighi; Claus-Dieter Schuh; Rolf M Nüsing; Yannick Schreiber; Nerea Ferreirós; Bernhard Brüne; Gerd Geisslinger; Sandra Pierre; Klaus Scholich
Journal:  J Biol Chem       Date:  2018-05-11       Impact factor: 5.157

9.  Altered expression of glial markers, chemokines, and opioid receptors in the spinal cord of type 2 diabetic monkeys.

Authors:  Norikazu Kiguchi; Huiping Ding; Christopher M Peters; Nancy D Kock; Shiroh Kishioka; J Mark Cline; Janice D Wagner; Mei-Chuan Ko
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2016-10-14       Impact factor: 5.187

10.  Hyperbaric Oxygen Alleviates the Inflammatory Response Induced by LPS Through Inhibition of NF-κB/MAPKs-CCL2/CXCL1 Signaling Pathway in Cultured Astrocytes.

Authors:  Su Liu; Chun Lu; Ying Liu; Xiaoyun Zhou; Li Sun; Qi Gu; Guangyu Shen; Aisong Guo
Journal:  Inflammation       Date:  2018-12       Impact factor: 4.092

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.